BEUDAMED
    FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

    Sensor, Glucose, Invasive, Component Of Automated Insulin Delivery System

    PMA: P250012 · Supplement: S010 · Decision May 26, 2026
    View on FDA
    Classifications
    1
    FEI Numbers
    0
    Registration Numbers
    0

    Research PMA P250012 in seconds

    The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

    Free to try · every answer cites its records

    Ask the Research Assistant See examples

    Basic Information

    Device Name
    Sensor, Glucose, Invasive, Component Of Automated Insulin Delivery System
    Trade Name
    Simplera and Simplera Sync
    PMA Number
    P250012
    Supplement Number
    S010
    Device Class
    FDA Class 3
    Product Code
    SFI
    Generic Name
    Sensor, Glucose, Invasive, Component of automated insulin delivery system
    Medical Specialty
    Unknown
    Advisory Committee
    Clinical Chemistry
    Decision
    30-Day Notice Accepted
    Decision Code
    OK30
    Decision Date
    May 26, 2026
    Date Received
    April 27, 2026
    Supplement Type
    30-Day Notice
    Supplement Reason
    Process Change - Manufacturer/Sterilizer/Packager/Supplier
    Expedited Review
    N

    Advisory Committee Statement

    to increase the capacity for the degassing of Simplera and Simplera Sync sensors by adding an additional degassing aeration room (Degassing Room #3) at a sterilization facility. The Simplera sensor is a component of the Simplera system. The Simplera Sync sensor is a component of the MiniMed 780G system. The Simplera Sync sensor is also approved for use with compatible cleared MiniMed devices

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    SFI Sensor, Glucose, Invasive, Component Of Automated Insulin Delivery System